Learning Boltzmann Generators via Constrained Mass Transport
Christopher von Klitzing, Denis Blessing, Henrik Schopmans, Pascal Friederich, Gerhard Neumann
TL;DR
This work tackles the challenge of sampling from high-dimensional, unnormalized targets by improving Boltzmann generators through Constrained Mass Transport (CMT). CMT formulates a sequence of intermediate densities connecting a tractable base to the target while enforcing both KL-distance and entropy-decay constraints, mitigating mass teleportation and mode collapse. The method is instantiated with normalizing flows, using a forward KL objective and a dual optimization scheme to learn intermediate densities efficiently, reusing samples via replay buffers. Empirically, CMT outperforms state-of-the-art variational BG methods on multiple alanine-based benchmarks and introduces the ELIL tetrapeptide, achieving over 2.5x higher effective sample size and better mode coverage without relying on MD samples. The results underscore the practical impact of constrained annealing paths for robust, scalable Boltzmann sampling in complex molecular systems.
Abstract
Efficient sampling from high-dimensional and multimodal unnormalized probability distributions is a central challenge in many areas of science and machine learning. We focus on Boltzmann generators (BGs) that aim to sample the Boltzmann distribution of physical systems, such as molecules, at a given temperature. Classical variational approaches that minimize the reverse Kullback-Leibler divergence are prone to mode collapse, while annealing-based methods, commonly using geometric schedules, can suffer from mass teleportation and rely heavily on schedule tuning. We introduce Constrained Mass Transport (CMT), a variational framework that generates intermediate distributions under constraints on both the KL divergence and the entropy decay between successive steps. These constraints enhance distributional overlap, mitigate mass teleportation, and counteract premature convergence. Across standard BG benchmarks and the here introduced ELIL tetrapeptide, the largest system studied to date without access to samples from molecular dynamics, CMT consistently surpasses state-of-the-art variational methods, achieving more than 2.5x higher effective sample size while avoiding mode collapse.
